Inogen names COO Andy Reding president and CEO, succeeding Kevin Smith

INGN•2026-11-05

Inogen appointed Chief Operating Officer Andy Reding president and CEO, succeeding Kevin Smith. Reding also joins the board of directors.

1. Leadership change

Inogen appointed COO Andy Reding president and CEO, succeeding Kevin Smith. Reding joined Inogen as COO in July 2026 and previously served as chief commercial officer at Viant Medical.

Inogen names COO Andy Reding president and CEO, succeeding Kevin Smith

1. Leadership change

Related News

Celestica grants President Steven Gregg Dorwart 1,017 restricted share units

Willdan Q3 net income $11.861 million

Perdoceo Education's Q3 revenue rises, beats estimates

Nephros Q3 revenue $5.6 million

Biodesix Q3 revenue misses estimates on seasonality impact, project delays